Therapy Areas: Hereditary Disorders
24 November 2021 - - The Spanish government has approved terms for the national reimbursement of Kaftrio (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with ivacaftor for the treatme...
12 November 2021 - - The European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion for the label extension of Kaftrio (ivacaftor/tezacaftor/elexacaftor...
4 November 2021 - - US-based biotechnology company Tessera Therapeutics has forged a treatment-focused collaboration with the Cystic Fibrosis Foundation using Tessera's Gene Writing technology to...
2 November 2021 - - US-based biotechnology company Adaptive Phage Therapeutics, Inc has entered into an agreement with the Antibacterial Resistance Leadership Group to support a multi-center Phase 1b/...
23 September 2021 - - US-based clinical-stage messenger RNA medicines company Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) has completed dosing of 100 subjects for the Phase 1 portion of the ARC...
21 September 2021 - - US-based clinical stage pharmaceutical company Renovion and the not-for-profit COPD Foundation have created a new partnership to accelerate the development of a novel therapy for...
Related Headlines